GEMINI SOMATICS ACQUIRES SIGNIFICANT
Submitted by Press@geminisomatics.com
12th November, 2010
Media Alert – Immediate Publication
Oregon, USA – For immediate release - Joseph Cavendish, Chairman and Founder of Gemini
Somatics, announced today that the group have secured significant investment to rejuvenate
their current research into neuropsychology, stem cell research, integrated memory encoding
and storage as well as the emerging science of synthetic somatology.
This investment has been confirmed as a result of an exciting new initiative funded by the
Clinical Research Association which aims to push through several persistent barriers in the
understanding and replication of higher brain functions, the applications of which will provide
profound global benefits.
Dr Edward Darmos, Executive Director of synthetic somatology at Gemini Somatics said:
“This extra funding will provide a great boost to the emerging science of synthetic somatology.
With this support, we can look to the future with greater optimism.”
About Gemini Somatics
Gemini Somatics is a world-leading medical research corporation working primarily in the field
of synthetic somatology, which is an emerging science developed by Dr Edward Darmos. The
group has developed a number of proprietary technologies to further development in this
exciting field, looking to the future of the human race.
If you are interested in the field of synthetic somatology or in joining Gemini Somatics please
visit Geminisomatics.com for more information.
All press enquiries should be directed to: Press@Geminisomatics.com